APA (7th ed.) Citation

Miele, E., Abballe, L., Spinelli, G. P., Besharat, Z. M., Catanzaro, G., Chiacchiarini, M., . . . Ferretti, E. (2020). BRAF mutant colorectal cancer: ErbB2 expression levels as predictive factor for the response to combined BRAF/ErbB inhibitors. BMC Cancer, 20(1), 1. https://doi.org/10.1186/s12885-020-6586-0

Chicago Style (17th ed.) Citation

Miele, Evelina, et al. "BRAF Mutant Colorectal Cancer: ErbB2 Expression Levels as Predictive Factor for the Response to Combined BRAF/ErbB Inhibitors." BMC Cancer 20, no. 1 (2020): 1. https://doi.org/10.1186/s12885-020-6586-0.

MLA (9th ed.) Citation

Miele, Evelina, et al. "BRAF Mutant Colorectal Cancer: ErbB2 Expression Levels as Predictive Factor for the Response to Combined BRAF/ErbB Inhibitors." BMC Cancer, vol. 20, no. 1, 2020, p. 1, https://doi.org/10.1186/s12885-020-6586-0.